Guy S. Goodwin-Gill Professor, University of New South Wales & Kaldor Centre for International Refugee Law, Sydney 23 October 2018...
One of Australia's most highly credentialled and internationally esteemed academics and university leaders, Professor Michael McRobbie AO, is to receive an Honorary Doctorate from Griffith University.
Exposure to a mild or symptom-free strain of Streptococcus pyogenes (Strep A) can trigger the body’s immune response and naturally build protection, potentially solving a nearly 100-year-old mystery of immunity.
Pictured left to right: Professor Michael Good AO, PDG Sandy Doumany OAM, Associate Professor Danielle Stanisic, Her Excellency the Honourable...
In a significant breakthrough, researchers from the Swiss Tropical and Public Health Institute (Swiss TPH) and Griffith University’s Institute for...
Griffith University’s Institute for Glycomics has received a $5 million philanthropic donation from the International Leducq Foundation to further the development of a Strep A vaccine.
Strep A (Streptococcus pyogenes) is a major cause of infection-related deaths, leading to over 500,000 fatalities annually. Developing countries, Indigenous populations, and vulnerable groups face the greatest risks. A potential vaccine, developed by Professor Michael Good's team at Griffith University, is undergoing human trials and shows promise in fighting multiple Strep A strains.
Griffith University, the Institute for Glycomics and Rotary are thrilled to announce The Honourable Anna Bligh AC will become the inaugural National Ambassador for its Malaria Vaccine Project.
A team of international scientists from Griffith University and the University of Alberta are about to start human clinical trials for a Strep A vaccine they hope will induce long-lasting immunity against the deadly pathogen which kills more than 500,000 people each year.
The Institute for Glycomics’ malaria vaccine researchers are one step closer to human trials for a malaria vaccine that can be freeze-dried.
